The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Analysis of the sensitivity to endocrine therapy (SET) assay in the PALLAS adjuvant trial of palbociclib in HR+/HER2- breast cancer (ABCSG-42/AFT-05/BIG-14-13).
 
Otto Metzger
Honoraria - AstraZeneca; Genzyme; Merck; SCIBR Foundation
Consulting or Advisory Role - Alliance for Clinical Trials in Oncology; Grupo Oncoclinicas; Resilience Care
Research Funding - Pfizer (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Grupo Oncoclinicas
 
Karla V. Ballman
Consulting or Advisory Role - Agenus; Takeda
Patents, Royalties, Other Intellectual Property - Prostate cancer signature patent (Inst)
Expert Testimony - Janssen Oncology; Mylan; Sanofi
 
Michael Gnant
Employment - Sandoz (I)
Honoraria - Amgen; AstraZeneca; Daiichi Sankyo Europe GmbH; EPG Health; Lilly; Menarini; MSD; Novartis; Pierre Fabre
Consulting or Advisory Role - AstraZeneca; Daiichi-Sankyo; Lilly; Menarini; MSD Oncology; Novartis; Veracyte
Expert Testimony - Lilly; Veracyte
Travel, Accommodations, Expenses - Lilly; Novartis
Other Relationship - ABCSG GmbH; ABCSG Research Services GmbH
 
Mark Watson
Research Funding - Alliance Foundation Trials (Inst)
 
Eveline Chen
No Relationships to Disclose
 
Kevin Tran
No Relationships to Disclose
 
Patrick O'Brien
Employment - Mayo Clinic
 
Dominik Hlauschek
Research Funding - Amgen (Inst); Amgen (Inst); Artera (Inst); AstraZeneca (Inst); Bristol Myers Squibb (Inst); Cepheid (Inst); Daiichi Sankyo (Inst); Novartis (Inst); OncoMark (Inst); Pfizer (Inst); Roche (Inst); Sandoz (Inst)
 
Miguel Martin
Honoraria - Lilly; Novartis; Pfizer; Pierre Fabre; Roche/Genentech; SEAGEN
Consulting or Advisory Role - AstraZeneca; Daiichi-Sankyo; Lilly; Novartis; Pfizer; Roche/Genentech
Speakers' Bureau - Lilly/ImClone; Lilly/ImClone; Pierre Fabre; Roche/Genentech
Research Funding - Novartis (Inst); Puma Biotechnology (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Daichii-Sankyo
Other Relationship - Novartis; Roche
 
Justin M Balko
Stock and Other Ownership Interests - Beam Therapeutics; BioNano Genomics; crispr therapeutics
Consulting or Advisory Role - AstraZeneca; Lilly; Malinkrodt; Pfizer
Research Funding - Genentech/Roche; Incyte
Patents, Royalties, Other Intellectual Property - FCRL6 as an immunotherapy target; Patent on use of HLA-DR/MHC expression to predict response to immunotherapies
Other Relationship - NanoString Technologies
 
Zbigniew Nowecki
No Relationships to Disclose
 
Olwen Mary Hahn
Employment - Solaris Health (I)
Leadership - Via Oncology
Stock and Other Ownership Interests - novavax; Procept Biorobotics; Teleflex Medical; Teleflex Medical
Honoraria - Cardinal Health (I); Teleflex Medical (I)
Consulting or Advisory Role - HMP; Pfizer; Teleflex Medical (I)
Travel, Accommodations, Expenses - Cardinal Health (I)
 
Carsten Denkert
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo; MSD Oncology
Research Funding - German Breast Group (Inst); Myriad Genetics (Inst)
Patents, Royalties, Other Intellectual Property - Patent WO2010076322A1; Patent WO2015114146A1; Patent WO2020109570A1; VMScope digital pathology software
 
Christina Curtis
No Relationships to Disclose
 
Yuan Liu
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Amylou C. Dueck
Honoraria - Novartis
 
Christian Fesl
Research Funding - Amgen (Inst); Pfizer (Inst)
 
Erica L. Mayer
Consulting or Advisory Role - AstraZeneca; Lilly; Novartis
 
Angela DeMichele
Consulting or Advisory Role - Pfizer (I)
Research Funding - Genentech (Inst); Inivata/NeoGenomics (Inst); Novartis (Inst); Pfizer (Inst)
 
W. Fraser Fraser Symmans
Stock and Other Ownership Interests - Delphi Diagnostics; Eiger BioPharmaceuticals; ISIS Pharmaceuticals
Consulting or Advisory Role - AstraZeneca; Merck
Patents, Royalties, Other Intellectual Property - Intellectual property; Intellectual Property (expired)
(OPTIONAL) Uncompensated Relationships - Delphi Diagnostics